Skip to main content
. 2024 Oct 15;14(10):4803–4816. doi: 10.62347/MWLI5585

Figure 5.

Figure 5

Predictive value of the combined model of LCP1 and ADPGK expression levels for PD-1 monoclonal antibody treatment-related immune-related adverse events in late-stage non-small cell lung cancer with KARS G12C mutation. Note: LCP1: Leukocyte-specific protein 1; ADPGK: adenosine diphosphate-dependent glucokinasel; KARS: lysyl-tRNA synthetase gene; AUC: Area Under the Curve.